These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 24353417)

  • 1. Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles.
    Xue M; Yang MX; Zhang W; Li XM; Gao DH; Ou ZM; Li ZP; Liu SH; Li XJ; Yang SY
    Int J Nanomedicine; 2013; 8():4677-87. PubMed ID: 24353417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice.
    Xue M; Zhang L; Yang MX; Zhang W; Li XM; Ou ZM; Li ZP; Liu SH; Li XJ; Yang SY
    Int J Nanomedicine; 2015; 10():5049-57. PubMed ID: 26346310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MgAl monolayer hydrotalcite increases the hypoglycemic effect of berberine by enhancing its oral bioavailability.
    Wang A; Yang W; Yang X; Mei X; Hu T; Liang R; Meng D; Yan D
    Biomed Pharmacother; 2020 Jul; 127():110140. PubMed ID: 32380387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spray-dried Solid Lipid Nanoparticles for Enhancing Berberine Bioavailability
    Nguyen VH; Le KNM; Nguyen MCN
    Curr Pharm Des; 2023; 29(38):3050-3059. PubMed ID: 37961862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoemulsion improves hypoglycemic efficacy of berberine by overcoming its gastrointestinal challenge.
    Xu HY; Liu CS; Huang CL; Chen L; Zheng YR; Huang SH; Long XY
    Colloids Surf B Biointerfaces; 2019 Sep; 181():927-934. PubMed ID: 31382342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine.
    Xiong W; Sang W; Linghu KG; Zhong ZF; Cheang WS; Li J; Hu YJ; Yu H; Wang YT
    Int J Nanomedicine; 2018; 13():3781-3793. PubMed ID: 29988733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
    Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
    Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.
    Deng J; Wu Z; Zhao Z; Wu C; Yuan M; Su Z; Wang Y; Wang Z
    Int J Nanomedicine; 2020; 15():3937-3951. PubMed ID: 32581538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing the antitumor activity of berberine hydrochloride by solid lipid nanoparticle encapsulation.
    Wang L; Li H; Wang S; Liu R; Wu Z; Wang C; Wang Y; Chen M
    AAPS PharmSciTech; 2014 Aug; 15(4):834-44. PubMed ID: 24696391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux.
    Shan YQ; Ren G; Wang YX; Pang J; Zhao ZY; Yao J; You XF; Si SY; Song DQ; Kong WJ; Jiang JD
    Metabolism; 2013 Mar; 62(3):446-56. PubMed ID: 23079743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect.
    Yin J; Hou Y; Yin Y; Song X
    Int J Nanomedicine; 2017; 12():8671-8680. PubMed ID: 29263662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrandrine potentiates the hypoglycemic efficacy of berberine by inhibiting P-glycoprotein function.
    Shan YQ; Zhu YP; Pang J; Wang YX; Song DQ; Kong WJ; Jiang JD
    Biol Pharm Bull; 2013; 36(10):1562-9. PubMed ID: 23924821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interactions between metformin and berberine in rats: Role of oral administration sequences and microbiota.
    Lyu Y; Zhang Y; Yang M; Lin L; Yang X; Cheung SCK; Shaw PC; Chan PKS; Kong APS; Zuo Z
    Life Sci; 2019 Oct; 235():116818. PubMed ID: 31473193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.
    Nazief AM; Hassaan PS; Khalifa HM; Sokar MS; El-Kamel AH
    Int J Nanomedicine; 2020; 15():1129-1148. PubMed ID: 32110012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
    Patel MH; Mundada VP; Sawant KK
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis.
    Zhou Y; Liu SQ; Peng H; Yu L; He B; Zhao Q
    Int Immunopharmacol; 2015 Sep; 28(1):34-43. PubMed ID: 26002585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models.
    Cheng Z; Chen AF; Wu F; Sheng L; Zhang HK; Gu M; Li YY; Zhang LN; Hu LH; Li JY; Li J
    Bioorg Med Chem; 2010 Aug; 18(16):5915-24. PubMed ID: 20663675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.
    Zhang N; Ping Q; Huang G; Xu W; Cheng Y; Han X
    Int J Pharm; 2006 Dec; 327(1-2):153-9. PubMed ID: 16935443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.